VivoSim Labs, Inc. Common Stock (VIVS)

Price$1.29

Growth ScoreC

Momentum ScoreF

Favorite Metrics

Price vs S&P 500 (26W)-55.56%

Price vs S&P 500 (4W)-14.00%

VGM Score30.53

Market Capitalization$3.39M

All Metrics

Book Value / Share (Quarterly)$1.70

P/TBV (Annual)0.36x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-54.21%

Cash Flow / Share (Quarterly)$-4.07

Price vs S&P 500 (YTD)-38.56%

Gross Margin (TTM)100.00%

Net Profit Margin (TTM)-864.08%

EPS (TTM)$1.07

10-Day Avg Trading Volume0.05M

EPS Excl Extra (TTM)$1.07

Revenue Growth (5Y)-42.03%

EPS (Annual)$-1.70

ROI (Annual)-23.71%

Gross Margin (Annual)96.53%

Net Profit Margin (5Y Avg)-4293.21%

Cash / Share (Quarterly)$1.64

Revenue Growth QoQ (YoY)8.33%

ROA (Last FY)-16.98%

Revenue Growth TTM (YoY)16.39%

EBITD / Share (TTM)$-4.80

ROE (5Y Avg)-124.91%

Operating Margin (TTM)-8066.20%

Cash Flow / Share (Annual)$-4.99

P/B Ratio0.76x

P/B Ratio (Quarterly)1.06x

Net Income / Employee (Annual)$-191,400

EV / Revenue (TTM)-6.32x

Net Interest Coverage (TTM)-4.05x

ROA (TTM)-11.34%

EPS Incl Extra (Annual)$-1.70

Current Ratio (Annual)3.25x

Quick Ratio (Quarterly)2.15x

3-Month Avg Trading Volume1.15M

52-Week Price Return-29.57%

Revenue / Employee (TTM)$10,900

P/S Ratio (Annual)23.54x

Asset Turnover (Annual)0.01x

52-Week High$5.30

Operating Margin (5Y Avg)-5827.01%

EPS Excl Extra (Annual)$-1.70

26-Week Price Return-39.63%

Quick Ratio (Annual)3.04x

13-Week Price Return-41.26%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)2.44x

Enterprise Value$-897,800

Revenue / Share Growth (5Y)-21.94%

Asset Turnover (TTM)0.01x

Revenue / Employee (Annual)$11,100

Inventory Turnover (Annual)0.03x

Pretax Margin (Annual)-1726.39%

Cash / Share (Annual)$5.96

3-Month Return Std Dev65.92%

Gross Margin (5Y Avg)84.18%

Net Income / Employee (TTM)$-94,400

ROE (Last FY)-23.71%

Net Interest Coverage (Annual)-257.00x

EPS Basic Excl Extra (Annual)$-1.70

Receivables Turnover (TTM)4.81x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$1.07

Receivables Turnover (Annual)4.57x

ROI (TTM)-15.56%

P/S Ratio (TTM)23.87x

Pretax Margin (5Y Avg)-4292.57%

Revenue / Share (Annual)$0.10

Tangible BV / Share (Annual)$5.53

Price vs S&P 500 (52W)-57.78%

Year-to-Date Return-27.62%

5-Day Price Return-3.68%

EPS Normalized (Annual)$-1.70

ROA (5Y Avg)-81.92%

Net Profit Margin (Annual)-1727.78%

Month-to-Date Return-8.39%

EBITD / Share (Annual)$-8.44

Operating Margin (Annual)-8761.11%

ROI (5Y Avg)-124.91%

EPS Basic Excl Extra (TTM)$1.07

P/B Ratio (Annual)0.36x

Inventory Turnover (TTM)0.03x

Pretax Margin (TTM)-862.68%

Book Value / Share (Annual)$5.53

Price vs S&P 500 (13W)-51.00%

Beta1.43x

Revenue / Share (TTM)$0.05

ROE (TTM)-15.56%

52-Week Low$1.22

gGradeC

mGradeF

vgmGradeD

Show chart for

Analyst Recommendations

Sep 2021

Oct 2021

Nov 2021

Dec 2021

2.29

Industry Peers — Biological Products(178)

Symbol	Value Score	Growth Score	Momentum Score	Price
VIVSVivoSim Labs, Inc. Common Stock	—	C	F	$1.29
AMGNAmgen Inc	C	C	C	$329.13
GILDGilead Sciences Inc	C	B	C	$131.10
ARGXargenx SE American Depositary Shares	D	A	C	$836.09
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	$163.68
BIIBBiogen Inc. Common Stock	B	D	B	$192.23
BNTXBioNTech SE American Depositary Share	C	C	C	$91.70
MRNAModerna, Inc. Common Stock	C	B	B	$46.06
NBIXNeurocrine Biosciences Inc	C	B	B	$161.00
EXELExelixis Inc	C	B	B	$50.28
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	$298.10

About

VivoSim Labs Inc (formerly Organovo Holdings Inc) is a biotechnology company developing FXR314 for inflammatory bowel disease, validated through its proprietary 3D human tissue modeling platform. The company also generates revenue through liver toxicology screening services and drug safety profiling offerings for pharmaceutical and biotech clients across all stages of drug development.